In today’s clinical trial landscape, “risk” is an omnipresent word. Every aspect of conducting a clinical trial has some inherent level of risk and decision makers continue to grapple with finding the best ways to identify risk, understand impact and proactively mitigate it. Recent regulatory changes like the implementation of ICH E6 R2 mandate companies […]
1996 – A year on the calendar which was punctuated with a number of firsts – DVDs were launched, the first mammal was cloned, eBay debuted as one of the hottest companies and closer to our space, the adoption of ICH E6 GCP became a reality. Oh and may I add that Google did not […]
Every time I hear this term being used, there is a part of me that freezes. The word “inspection” brings back the same sense of dread I used to have as a kid when I needed to prepare for an exam.
Brexit has been the talk of town following Britain’s recent decision to leave the European Union. Headlines are flying and the conversation is only strengthening around the impact this decision will have on industries of all kinds – including the pharma industry.